BRIEF-Kuros Biosciences Announces U.S. FDA Approval Of IND Application
1 Min Read
Sept 3 (Reuters) - Kuros Biosciences AG:
* ANNOUNCES U.S. FDA APPROVAL OF IND APPLICATION TO INITIATE FIBRIN-PTH PHASE 2A CLINICAL TRIAL IN SPINAL FUSION Source text for Eikon: Further company coverage: (Gdynia Newsroom)